drugset / Trial / NCT01775098

Allopurinol in Acute Gout

NCT01775098 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

Timeline

Start
—
Primary completion
2012-12
Completion
2013-02

Outcome

Outcome not reported

Stopped (Business): “because of a lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule — —

Indications